Warby Parker Inc. WRBY
We take great care to ensure that the data presented and summarized in this overview for Warby Parker Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding WRBY
View all-
Vanguard Group Inc Valley Forge, PA9.8MShares$238 Million0.0% of portfolio
-
Durable Capital Partners LP Bethesda, MD8.18MShares$199 Million1.0% of portfolio
-
D1 Capital Partners L.P. New York, NY7.86MShares$191 Million3.4% of portfolio
-
Black Rock Inc. New York, NY7.25MShares$176 Million0.0% of portfolio
-
General Catalyst Group Management, LLC5.66MShares$137 Million6.78% of portfolio
-
Marshall Wace, LLP London, X03.3MShares$80.1 Million0.07% of portfolio
-
Vaughan Nelson Investment Management, L.P.2.56MShares$62.1 Million0.37% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL2.35MShares$57.2 Million0.01% of portfolio
-
Gilder Gagnon Howe & CO LLC New York, NY2.27MShares$55.2 Million0.47% of portfolio
-
State Street Corp Boston, MA2.21MShares$53.7 Million0.0% of portfolio
Latest Institutional Activity in WRBY
Top Purchases
Top Sells
About WRBY
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Insider Transactions at WRBY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 11
2024
|
Steven Clive Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,016
-3.71%
|
$161,368
$23.85 P/Share
|
Dec 11
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
54,000
-81.44%
|
$1,242,000
$23.84 P/Share
|
Dec 11
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
54,000
+44.89%
|
-
|
Dec 10
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
304,947
-96.12%
|
$7,013,781
$23.5 P/Share
|
Dec 10
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
304,947
+49.01%
|
-
|
Dec 09
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-80.42%
|
$1,150,000
$23.65 P/Share
|
Dec 09
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
50,000
+44.57%
|
-
|
Dec 03
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,163
-74.81%
|
$795,586
$22.61 P/Share
|
Dec 03
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
36,163
+42.79%
|
-
|
Dec 03
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,163
-74.61%
|
$795,586
$22.61 P/Share
|
Dec 03
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
36,163
+42.73%
|
-
|
Dec 03
2024
|
Steven Clive Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,853
-7.28%
|
$326,766
$22.61 P/Share
|
Dec 03
2024
|
Steven Clive Miller Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,511
+11.5%
|
-
|
Oct 18
2024
|
Ronald A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
415
+0.5%
|
-
|
Sep 11
2024
|
Steven Clive Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,763
-3.67%
|
$87,919
$13.9 P/Share
|
Sep 10
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
49,034
-79.94%
|
$637,442
$13.69 P/Share
|
Sep 10
2024
|
David Abraham Gilboa Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
49,034
+44.43%
|
-
|
Sep 09
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-41.66%
|
$700,000
$14.03 P/Share
|
Sep 09
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
50,000
+44.57%
|
-
|
Sep 06
2024
|
Neil Harris Blumenthal Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
27,143
-69.03%
|
$352,859
$13.0 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 194K shares |
---|---|
Conversion of derivative security | 1.05M shares |
Exercise of conversion of derivative security | 270K shares |
Open market or private purchase | 75K shares |
Open market or private sale | 6.87M shares |
---|